Why Long COVID May Change How We Understand Chronic Lyme Disease

Persistent symptoms can follow an infection
Routine tests may not explain continuing illness
Long COVID research may offer broader lessons

Long COVID may change how medicine understands chronic Lyme disease by encouraging broader recognition of persistent symptoms after infection. For decades, patients with fatigue, cognitive dysfunction, pain, and autonomic symptoms following infections have often faced skepticism and limited treatment options.

The emergence of long COVID has renewed scientific interest in what researchers call infection-associated chronic conditions—illnesses that begin after an infection and may continue beyond the acute stage.

What Are Infection-Associated Chronic Conditions?

Researchers increasingly use the term infection-associated chronic conditions, or IACCs, to describe illnesses in which symptoms begin during or after an infection and continue beyond the expected recovery period.

These conditions have been described after several pathogens, including:

• SARS-CoV-2
• Epstein-Barr virus
• Enteroviruses
• Borrelia burgdorferi, the bacterium associated with Lyme disease
• Giardia and other infectious organisms

Although the triggering pathogens differ, patients may report similar symptoms, including fatigue, cognitive impairment, pain, autonomic dysfunction, sleep disturbance, and reduced physical capacity.

These similarities do not mean the conditions are identical or have the same cause. They suggest that studying them together may reveal biological pathways that would be more difficult to recognize when each illness is examined separately.

Why Long COVID Changed the Conversation

Long COVID emerged during a global pandemic in which millions of people experienced infection within a relatively short period. Because the timing of infection was often identifiable, persistent symptoms could be recognized more readily than in many earlier infection-associated illnesses.

This visibility has made it more difficult to dismiss continuing symptoms as entirely psychological or unrelated to a preceding infection.

For patients with chronic Lyme disease, this shift matters. Long COVID has demonstrated on a massive scale that recovery from an acute infection does not always mean an immediate return to previous health.

It has also generated scientific interest that may eventually benefit patients with Lyme disease, ME/CFS, dysautonomia, and other infection-associated chronic conditions.

Why Diagnosis Is Often Difficult

One of the greatest challenges in studying infection-associated chronic conditions is that the triggering infection may no longer be detectable when persistent symptoms are evaluated.

Some initial infections are mild, atypical, or never recognized. By the time fatigue, cognitive problems, pain, or autonomic symptoms are assessed weeks or months later, routine testing may not provide a complete explanation.

This diagnostic gap has contributed to decades of uncertainty surrounding ME/CFS, long COVID, and persistent symptoms following Lyme disease.

Clinicians must still investigate other possible explanations. However, inconclusive testing should not automatically be interpreted as proof that nothing is wrong. Clinical history, exposure risk, symptom evolution, functional changes, and longitudinal observation remain important.

Shared Symptoms Across Infection-Associated Illnesses

Patients with long COVID and persistent symptoms following Lyme disease may describe similar patterns, including:

• Fatigue
• Post-exertional worsening
• Brain fog
• Memory or concentration problems
• Dizziness or autonomic instability
• Sleep disturbance
• Muscle, joint, or nerve pain
• Functional decline despite unrevealing routine testing

These similarities may point toward overlapping biological pathways. Symptoms alone, however, cannot establish the underlying diagnosis. Lyme disease, long COVID, sleep disorders, endocrine abnormalities, medication effects, autoimmune diseases, and other conditions can produce some of the same complaints.

Possible Biological Mechanisms

Researchers studying long COVID are investigating several mechanisms that may also be relevant to other infection-associated chronic illnesses:

• Immune dysregulation
• Persistent inflammation
• Autonomic nervous system dysfunction
• Endothelial or coagulation abnormalities
• Reactivation of latent viruses
• Persistence of microbial material or antigens
• Tissue injury following the original infection

Not every mechanism will apply equally to every illness or every patient. Long COVID research also cannot determine by itself whether persistent Lyme disease symptoms reflect ongoing infection, immune changes, tissue injury, another diagnosis, or a combination of factors.

It may, however, provide new tools for investigating these possibilities.

Sex Differences in Infection-Associated Illness

Long COVID and ME/CFS are reported more often in women, as are several autoimmune diseases. Researchers are investigating whether differences in immune regulation, inflammatory responses, hormones, genetics, or other factors influence vulnerability to persistent illness.

These patterns are not yet fully understood. Studying them may help explain why some individuals recover promptly after an infection while others develop prolonged symptoms.

Medical Humility When Tests Are Inconclusive

A 2025 editorial by Thomas includes post-treatment Lyme disease syndrome among infection-associated chronic conditions and calls for greater humility when medicine does not have all the answers.

Medical humility does not mean abandoning scientific standards or accepting every proposed explanation. It means recognizing the limits of current knowledge while continuing to evaluate and support the patient.

A normal test can help exclude a particular diagnosis, but it does not necessarily explain why someone remains ill. Instead of simply telling a patient that everything is normal, clinicians can explain what has been ruled out, what remains uncertain, and what additional evaluation or symptom management may be appropriate.

Why Patients Have Felt Dismissed

When standard testing fails to explain persistent symptoms, patients may be told that nothing is wrong. For many people with chronic Lyme disease or other infection-associated conditions, this has led to years of uncertainty and frustration.

Long COVID has exposed an important limitation of modern medicine: available diagnostic tests do not capture every biological process that may impair a patient’s health.

Psychological health remains an important part of comprehensive care, particularly because prolonged illness can contribute to anxiety or depression. However, psychological explanations should not be used prematurely to end an appropriate medical evaluation.

Clinical Perspective

In my clinical practice, patients with persistent symptoms following Lyme disease often describe patterns now widely discussed in long COVID—fatigue, cognitive slowing, fluctuating function, post-exertional worsening, and autonomic symptoms.

Long COVID has not resolved the controversies surrounding chronic Lyme disease. Nor does similarity between the conditions establish that they have the same cause or require the same treatment.

It has made one point increasingly difficult to ignore: persistent symptoms after infection can be real, disabling, and biologically complex. These patients deserve careful evaluation, respectful communication, and continued scientific investigation.

Frequently Asked Questions

Are long COVID and chronic Lyme disease the same illness?

No. They follow different infections and may involve different biological mechanisms. However, patients can experience overlapping symptoms such as fatigue, brain fog, pain, sleep problems, and autonomic dysfunction.

What can long COVID research teach us about chronic Lyme disease?

Long COVID research may improve understanding of immune dysregulation, inflammation, autonomic dysfunction, microbial antigens, tissue injury, and other mechanisms that could contribute to persistent symptoms following infections.

Do normal tests rule out an infection-associated chronic condition?

No single routine test can identify every infection-associated chronic condition. Normal results may help rule out specific diagnoses, but they do not necessarily explain persistent symptoms or functional decline.

Does symptom overlap prove that long COVID and chronic Lyme disease require the same treatment?

No. Similar symptoms do not establish a shared cause or treatment. Patients require an individualized evaluation that considers the original infection, other medical conditions, symptom patterns, and potentially treatable causes.

Clinical Takeaway

Long COVID has not settled the scientific questions surrounding persistent symptoms after Lyme disease. It has provided medicine with a major opportunity to investigate why some patients do not regain their previous health after an infection.

The absence of a definitive biomarker should encourage careful differential diagnosis and follow-up rather than automatic dismissal of persistent, function-limiting symptoms.

Clinicians can acknowledge uncertainty while continuing to investigate treatable causes, address symptoms, and take the patient’s loss of function seriously.

Related Articles

Lyme disease and Long COVID
Persistent Lyme disease overview
Autonomic dysfunction and Lyme disease
Recovery from Lyme disease

References

1. Peluso MJ, Hanson MR, Deeks SG. Infection-associated chronic conditions: Why long COVID is our best chance to untangle Osler’s Web. Science Translational Medicine. 2024;16(773):eado2101.
2. Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: Road map to the literature. Frontiers in Medicine. 2023;10:1187163.
3. Asch ES, Bujak DI, Weiss M, Peterson MGE, Weinstein A. Lyme disease: An infectious and postinfectious syndrome. Journal of Rheumatology. 1994;21(3):454–461.
4. Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of post-Lyme syndrome. Journal of Rheumatology. 1996;23(8):1392–1397.
5. Thomas LDL. When we don’t have all the answers: Long COVID and the need for humility in medicine. Ochsner Journal. 2025;25(3):152–158.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention